home *** CD-ROM | disk | FTP | other *** search
- Path: sparky!uunet!zaphod.mps.ohio-state.edu!cis.ohio-state.edu!rutgers!concert!samba!usenet
- From: Manish.Agarwal@launchpad.unc.edu (Manish Agarwal)
- Newsgroups: misc.invest
- Subject: any opinions on glaxo???
- Keywords: glaxo, investment, stocks
- Message-ID: <1992Dec21.171016.24009@samba.oit.unc.edu>
- Date: 21 Dec 92 17:10:16 GMT
- Sender: usenet@samba.oit.unc.edu
- Distribution: usa
- Organization: University of North Carolina Extended Bulletin Board Service
- Lines: 19
- Nntp-Posting-Host: lambada.oit.unc.edu
-
- hello netters.
-
- i was curious to know if anyone had any opinions on investing in glaxo.
- their anti-migrain drug has been approved in europe and is up for approval
- in the U.S.. the stock is also trading at a low of about $24-25 on NYSE.
- 40% of their sales are from the U.S. market (will clinton's new policies
- severly affect glaxo?). in size they're second worldwide, behind
- merck...but first in terms of percentage of sales spending in terms of
- R&D. appears a good long-term buy to me...
-
- manish agarwal
- georgetown university
-
- agarwal@guvax.georgetown.edu
- --
- The opinions expressed are not necessarily those of the University of
- North Carolina at Chapel Hill, the Campus Office for Information
- Technology, or the Experimental Bulletin Board Service.
- internet: laUNChpad.unc.edu or 152.2.22.80
-